Aripiprazole in Pervasive Developmental Disorder Not Otherwise Specified and Asperger's Disorder: A 14-Week, Prospective, Open-Label Study

Journal of Child and Adolescent Psychopharmacology - United States
doi 10.1089/cap.2008.093